-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C1uY8sUk3mNusHw9MAbSHepsMrGV9xtJTW4dzwm4vo254uf9my7DMynf8DxEI9Q3 gWLMJ9qtpcqGfmcidH6e1A== 0001209191-08-012271.txt : 20080221 0001209191-08-012271.hdr.sgml : 20080221 20080221202519 ACCESSION NUMBER: 0001209191-08-012271 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080219 FILED AS OF DATE: 20080221 DATE AS OF CHANGE: 20080221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cole G Bradley CENTRAL INDEX KEY: 0001337798 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 08634482 BUSINESS ADDRESS: BUSINESS PHONE: 650-569-2290 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-02-19 0 0001131324 GENOMIC HEALTH INC GHDX 0001337798 Cole G Bradley 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 EVP & CFO Common Stock 2008-02-19 4 S 0 4000 22.6024 D 8298 D Common Stock 2008-02-19 4 M 0 5000 1.33 A 13298 D Common Stock 2008-02-19 4 S 0 5000 22.5672 D 8298 D Employee Stock Option (right to buy) 1.33 2008-02-19 4 M 0 5000 0.00 D 2014-07-06 Common Stock 5000 151033 D This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on December 4, 2007. The number of shares originally covered by the exercised option was 150,000 with an exercise price per share of $1.38. In connection with the issuer's initial public offering on October 4, 2005, a conditional dividend was issued which increased the number of shares covered by the option by 6,033 to 156,033, reducing the effective exercise price per share to $1.33. The option becomes exercisable as to 25% of the shares, or 39,009 shares, on July 6, 2005, and becomes exercisable as to 1/48th of the shares, or 3,250.67 shares, each full month thereafter. G. Bradley Cole 2008-02-21 -----END PRIVACY-ENHANCED MESSAGE-----